Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 775 of 2228 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/27/25
End: 06/03/26
Due: 06/03/27
Phase: N/A
Priority: Normal
Start: 08/04/25
End: 01/26/26
Due: 01/26/27
Phase: N/A
Priority: Normal
Start: 09/12/24
End: 03/06/26
Due: 03/06/27
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 05/12/25
Due: 05/12/26
Phase: N/A
Priority: Normal
Start: 12/13/23
End: 08/29/25
Due: 08/29/26
Phase: N/A
Priority: Normal
Start: 12/30/24
End: 12/30/30
Due: 12/30/31
Phase: N/A
Priority: Normal
Start: 02/03/25
End: 12/29/25
Due: 12/29/26
Phase: N/A
Priority: Normal
Start: 01/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/28/17
End: 11/28/19
Due: 11/28/20
Phase: N/A
Priority: Normal
Start: 03/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/27/25
End: 06/29/26
Due: 06/29/27
Phase: N/A
Priority: Normal
Start: 01/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 01/31/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/23/17
End: 03/05/18
Due: 03/05/19
Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects
Phase: N/A
Priority: Normal
Start: 09/30/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/05/25
End: 09/29/27
Due: 09/29/28
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 02/28/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 05/31/08
End: -
Due: -